Assessing care for low-risk patients


Researchers at the Masonic Cancer Center, University of Minnesota are dedicated not only to finding ways to detect, prevent, and treat cancer, but also to improving patient outcomes by assessing the care provided by clinics, centers, and hospitals.

In recent years, there has been a national push to treat cancer patients at accredited hospitals or centers of excellence that see more patients and offer more complex procedures.

Although many have benefited from this approach, Schelomo Marmor, M.P.H., Ph.D., a researcher in the U’s surgery department, is interested in whether it makes a difference for lower-risk patients.

With Masonic pilot support, Marmor and colleagues Todd Tuttle, M.D., and Eric Jensen, M.D., are examining data from cancer patients nationwide to determine if lower-risk individuals are better served receiving care closer to home and at centers focused on fewer patients and procedures.

Once their work is complete, they hope it will lead to positive change in health care delivery by giving providers the tools to guide patients to the best care possible.

“I enjoy working on quality improvement projects because it’s about improving the lives of our patients by optimizing flow, saving costs, and easing the burden of care,” says Marmor.


Anne Blaes
While chemotherapy drugs can slow or stop the growth of cancer, they can also cause adverse health impacts in cancer survivors.
Beshay Zordoky
While advanced therapies have improved cancer survival rates, many of these medications can lead to cardiovascular disease later in life.